3. Designing and Running Robust Trials

Why randomisation and controls are important

Watch this video to find out why randomisation and controls are important in randomised controlled clinical trials. (5:53)

Explore more about this topic in these videos:

 

Defining a research question using Population, Intervention, Control, Outcome, Timing (PICOT)

Watch this video to find out how a trial question can be defined using PICOT. (13:21)

Download PICOT presentation slides (pdf).

Exercise 1: What is the PICOT of the LATA trial? (Microsoft Forms)

Exercise 2: Define your own PICOT (Microsoft Forms)

Explore more about the importance of PPI in developing the PICOT:

 

Types of trial designs and when to use them

Watch this video to find out about different phase III clinical trial designs (including multi-arm multi-stage (MAMS), umbrella, basket, factorial, and cluster randomised trials), and when they might be helpful. (14:29)

Download Trial Designs presentation slides (pdf).

Explore more about the MAMS design:

 

Concepts of bias, blinding and placebos

Watch this video to explore the concepts of bias, blinding and placebos. (6:22)

Download Bias, blinding and placebos presentation slides (pdf).

 

What influences sample size

Watch this video to explore the factors that influence sample size in clinical trials. (6:47)

Download Sample Size presentation slides (pdf).

 

What is ‘generalisability’ and why is it important

Watch this video to explore what "generalisability" of a randomised clinical trial is and the importance of this. (4:53)

Download Generalisability presentation slides (pdf)

 

Designing trials that encourage diversity and inclusion

Watch this video to explore diversity in clinical trials. (5:47)  

Download Diversity in Trials presentation slides (pdf)

Exercise: Barriers to participation (Microsoft Forms)

Explore more about diversity in trials:

Feedback form for the PPI training